KS

Kok Sim

Chief Executive Officer

Biobot Surgical

Singapore


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Biobot Surgical
Industry
medical devices
Employees
42.0
Seniority
C suite
Annual Revenue
4000000.0
Total Funding
18000000.0
Latest Funding
Series B

Technologies

Outlook Microsoft Office 365 Google Maps WordPress.org reCAPTCHA Linkedin Marketing Solutions Mobile Friendly Google Maps (Non Paid Users) Google Analytics Google Tag Manager YouTube Apache Hubspot

Keywords

urology prostate cancer robotic surgery minimallyinvasive prostate biopsy prostate diagnosis biopsy transperineal procedures robot-assisted technology mri ultrasound fusion precision diagnostics needle positioning surgical robotics clinical workflows patient outcomes advanced visualization cancer detection infection risk reduction soft tissue ablation medical technology urology advancements biopsy planning transrectal biopsy alternatives surgical systems robotic accuracy human-centered design clinical evidence healthcare innovation surgical instruments digital infrastructure development pipeline regulatory clearances clinical safety market research real-world evidence global collaboration patient care surgical techniques biomedical devices medical imaging cancer treatment prostate healthcare solutions multi-disciplinary approach patient-centered care healthcare technology robotic platforms surgical advancements healthcare stakeholders medical device efficiency robot-assisted surgeries

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans